Demling R H
Department of Surgery, Harvard Medical School, Boston, Massachusetts 02115, USA.
Annu Rev Med. 1995;46:193-202. doi: 10.1146/annurev.med.46.1.193.
Adult respiratory distress syndrome (ARDS) remains a highly lethal complication of autodestructive inflammation. This syndrome originally referred to a single organ failure but is now considered a component, usually the first, of the multisystem organ failure syndrome (MOFS). Cytokines, neutrophils, and endothelial adherence molecules initiate the disease process, with cell injury caused by oxidants and proteases released from inflammatory cells. ARDS, if progressive, will result in pulmonary fibrosis. Improved ventilatory support techniques have not been shown to decrease mortality. Pharmacologic manipulation of the inflammatory response is a more promising method of controlling the disease process.
成人呼吸窘迫综合征(ARDS)仍然是自身破坏性炎症的一种高致死性并发症。该综合征最初指单一器官衰竭,但现在被认为是多系统器官衰竭综合征(MOFS)的一个组成部分,通常是首个组成部分。细胞因子、中性粒细胞和内皮黏附分子启动疾病进程,炎症细胞释放的氧化剂和蛋白酶导致细胞损伤。如果病情进展,ARDS将导致肺纤维化。尚未证明改进的通气支持技术能降低死亡率。对炎症反应进行药物调控是控制疾病进程更有前景的方法。